A Study of XZP-3287 in Combination With Fulvestrant in Patients With Advanced Breast Cancer
Clinical trial NCT05077449 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05077449
- Sponsor
- Xuanzhu Biopharmaceutical Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-16
- Primary completion
- 2024-02-22
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.